Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,996,650
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
43,302,427
-
Shares change
-
+1,822,197
-
Total reported value, excl. options
-
$429,553,897
-
Value change
-
+$13,144,675
-
Number of buys
-
38
-
Number of sells
-
21
-
Price
-
$9.92
Institutional Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) as of Q1 2022
As of 31 Mar 2022 Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) had 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 43,302,427 shares of stock of the company.
Largest 10 holders included Canaan Partners XI LLC, Atlas Venture Life Science Advisors, LLC, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, BOXER CAPITAL, LLC, and BlackRock Inc..
This table shows 66 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.